Skip to main content Accessibility help

Detection of high levels of anti-α-galactosyl antibodies in sera of patients with Old World cutaneous leishmaniasis: a possible tool for diagnosis and biomarker for cure in an elimination setting



In the Kingdom of Saudi Arabia (KSA), Old World cutaneous leishmaniasis (CL) is mainly caused by Leishmania major and Leishmania tropica parasites. Diagnosis of CL is predominately made by clinicians, who at times fail to detect the disease and are unable to identify parasite species. Here, we report the development of a chemiluminescent enzyme-linked immunosorbent assay (CL-ELISA) to measure the levels of anti-α-galactosyl antibodies in human sera. Using this assay, we have found that individuals infected with either Leishmania spp. had significantly elevated levels (up to 9-fold higher) of anti-α-Gal IgG compared to healthy control individuals. The assay sensitivity was 96% for L. major (95% CI; 94–98%) and 91% for L. tropica (95% CI; 86–98%) infections and therefore equivalent to restriction fragment length polymorphism-polymerase chain reaction analysis of parasite ITS1 gene. In addition, the assay had higher sensitivity than microscopy analysis, which only detected 68 and 45% of the L. major and L. tropica infections, respectively. Interestingly, up to 2 years following confirmed CL cure individuals had 28-fold higher levels of anti-α-Gal IgG compared to healthy volunteers. Monitoring levels of anti-α-Gal antibodies can be exploited as both a diagnostic tool and as a biomarker of cure of Old World CL in disease elimination settings.


Corresponding author

*Corresponding author: Department of Parasitology and Department of Vector Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK. E-mail:


Hide All
Almeida, I. C. (2014). Lytic anti-alpha-galactosyl antibodies as reliable biomarkers for the follow-up of Chagas disease chemotherapy. Revista Española de Salud Pública 88, 916.
Almeida, I. C., Milani, S. R., Gorin, P. A. and Travassos, L. R. (1991). Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies. Journal of Immunology 146, 23942400.
Almeida, I. C., Krautz, G. M., Krettli, A. U. and Travassos, L. R. (1993). Glycoconjugates of Trypanosoma cruzi: a 74 kD antigen of trypomastigotes specifically reacts with lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas disease. Journal of Clinical Laboratory Analysis 7, 307316.
Almeida, I. C., Ferguson, M. A., Schenkman, S. and Travassos, L. R. (1994). Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas’ disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochemical Journal 304, 793802.
Almeida, I. C., Covas, D. T., Soussumi, L. M. and Travassos, L. R. (1997). A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection. Transfusion 37, 850857.
Alvar, J., Velez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., den Boer, M. and Team, W. H. O. L. C. (2012). Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7, e35671.
al-Zahrani, M. A., Peters, W., Evans, D. A., Smith, V. and Ching Chin, I. (1989). Leishmania infecting man and wild animals in Saudi Arabia. 6. Cutaneous leishmaniasis of man in the south-west. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 621628.
Andrade, A. L., Martelli, C. M., Oliveira, R. M., Silva, S. A., Aires, A. I., Soussumi, L. M., Covas, D. T., Silva, L. S., Andrade, J. G., Travassos, L. R. and Almeida, I. C. (2004). Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up. American Journal of Tropical Medicine and Hygiene 71, 594597.
Ashmus, R. A., Schocker, N. S., Cordero-Mendoza, Y., Marques, A. F., Monroy, E. Y., Pardo, A., Izquierdo, L., Gallego, M., Gascon, J., Almeida, I. C. and Michael, K. (2013). Potential use of synthetic alpha-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease. Organic and Biomolecular Chemistry 11, 55795583.
Avila, J. L., Rojas, M. and Garcia, L. (1988). Persistence of elevated levels of galactosyl-alpha(1–3)galactose antibodies in sera from patients cured of visceral leishmaniasis. Journal of Clinical Microbiology 26, 18421847.
Avila, J. L., Rojas, M. and Galili, U. (1989). Immunogenic Gala1-3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania. Journal of Immunology 142, 28282834.
Avila, J. L., Rojas, M. and Acosta, A. (1991). Glycoinositol phospholipids from American Leishmania and Trypanosoma spp.: partial characterization of the glycan cores and the human humoral immune response to them. Journal of Clinical Microbiology 29, 23052312.
de Andrade, A. L., Zicker, F., de Oliveira, R. M., Almeida Silva, S., Luquetti, A., Travassos, L. R., Almeida, I. C., de Andrade, S. S., de Andrade, J. G. and Martelli, C. M. (1996). Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 348, 14071413.
El-Beshbishy, H. A., Al-Ali, K. H. and El-Badry, A. A. (2013). Molecular characterization of cutaneous leishmaniasis in Al-Madinah Al-Munawarah province, western Saudi Arabia. International Journal of Infectious Diseases 17, e334338.
Elbihari, S., Kawasmeh, Z. A., Al-Naiem, A. and Al-Atiya, S. (1987). Leishmania infecting man and wild animals in Saudi Arabia. 3. Leishmaniasis in Psammomys obesus Cretzschmar in Al-Ahsa oasis. Tropical Medicine and Parasitology 38, 8992.
el Tai, N. O., Osman, O. F., el Fari, M., Presber, W. and Schonian, G. (2000). Genetic heterogeneity of ribosomal internal transcribed spacer in clinical samples of Leishmania donovani spotted on filter paper as revealed by single-strand conformation polymorphisms and sequencing. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 575579.
Galili, U. (1993). Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody. Springer Seminars in Immunopathology 15, 155171.
Gazzinelli, R. T., Pereira, M. E., Romanha, A., Gazzinelli, G. and Brener, Z. (1991). Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies. Parasite Immunology 13, 345356.
Hotez, P. (2013). “Aleppo Evil” : The Ulcer, the Boil, the Sandfly, and the Conflict.قرحةحلبthe-ulcer-the-boil-the-sandfly-and-the-conflict/.
Izquierdo, L., Marques, A. F., Gallego, M., Sanz, S., Tebar, S., Riera, C., Quinto, L., Aldasoro, E., Almeida, I. C. and Gascon, J. (2013). Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic setting. Memórias do Instituto Oswaldo Cruz 108, 928931.
Killick-Kendrick, R., Bryceson, A. D., Peters, W., Evans, D. A., Leaney, A. J. and Rioux, J. A. (1985). Zoonotic cutaneous leishmaniasis in Saudi Arabia: lesions healing naturally in man followed by a second infection with the same zymodeme of Leishmania major. Transactions of the Royal Society of Tropical Medicine and Hygiene 79, 363365.
McConville, M. J., Homans, S. W., Thomas-Oates, J. E., Dell, A. and Bacic, A. (1990). Structures of the glycoinositolphospholipids from Leishmania major. A family of novel galactofuranose-containing glycolipids. Journal of Biological Chemistry 265, 73857394.
McConville, M. J., Schnur, L. F., Jaffe, C. and Schneider, P. (1995). Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species. Biochemical Journal 310, 807818.
Milani, S. R. and Travassos, L. R. (1988). Anti-alpha-galactosyl antibodies in chagasic patients. Possible biological significance. Brazilian Journal of Medical and Biological Research 21, 12751286.
Morsy, T. A., al Dakhil, M. A. and el Bahrawy, A. F. (1997). Characterization of Leishmania aethiopica from rock hyrax, Procavia capensis trapped in Najran, Saudi Arabia. Journal of the Egyptian Society of Parasitology 27, 349353.
Postigo, J. A. (2010). Leishmaniasis in the World Health Organization Eastern Mediterranean Region. International Journal of Antimicrobial Agents 36, 6265.



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed